| Schedule of deferred tax assets and liabilities |
| Schedule of deferred tax assets and liabilities |
|
|
|
|
|
|
| |
|
June 30,
2022
|
|
|
December 31,
2021
|
|
| Deferred tax assets |
|
|
|
|
|
|
|
|
| Net operating losses |
|
$ |
8,366,985 |
|
|
$ |
5,078,075 |
|
| Depreciation and amortization |
|
|
225,385 |
|
|
|
46,030 |
|
| Research & development credit |
|
|
592,276 |
|
|
|
592,276 |
|
| Lease liability |
|
|
170,325 |
|
|
|
466,980 |
|
| Stock-based compensation |
|
|
3,276,471 |
|
|
|
2,872,973 |
|
| Accrued expenses |
|
|
506,680 |
|
|
|
478,171 |
|
| Other |
|
|
2,226 |
|
|
|
336 |
|
| Total |
|
|
13,140,348 |
|
|
|
9,534,840 |
|
| Valuation allowance |
|
|
(13,140,348 |
) |
|
|
(9,076,492 |
) |
| Net deferred tax asset |
|
|
168,177 |
|
|
|
458,348 |
|
| Deferred tax liabilities |
|
|
|
|
|
|
|
|
| Right of use assets |
|
|
(168,177 |
) |
|
|
(458,348 |
) |
| Total net deferred taxes deferred tax liabilities |
|
$ |
– |
|
|
$ |
– |
|
|